Tech Company Financing Transactions

Rectify Pharmaceuticals Funding Round

Atlas Venture, Forbion Capital Partners and Longwood Fund participated in a $100 million Series A capital raise for Rectify Pharmaceuticals. The round was recorded on 10/18/2021.

Transaction Overview

Company Name
Rectify Pharmaceuticals
Announced On
10/18/2021
Transaction Type
Venture Equity
Amount
$100,000,000
Round
Series A
Investors

Atlas Venture (Lead Investor) (Jason Rhodes)

Forbion Capital Partners (Lead Investor) (Marco Boorsma)

Longwood Fund (Lead Investor) (David Steinberg)

Omega Funds (Lead Investor) (Otello Stampacchia)

Proceeds Purpose
Rectify plans to use this financing to fund the company through its first human proof-of-concept (POC) studies.

Company Information

Company Status
Private & Independent
Industry
Biopharmaceutical
Mailing Address
300 Technology Sq. 8th Floor
Cambridge, MA 02139
USA
Phone
Undisclosed
Website
www.rectifypharma.com
Email Address
[email protected]
Overview
Rectify is developing Positive Functional Modulators (PFMs), disease-modifying precision therapeutics that restore ABC transporter function for patients with serious genetic diseases.
Profile
Rectify Pharmaceuticals LinkedIn Company Profile
Social Media
Rectify Pharmaceuticals Company Twitter Account
Company News
Rectify Pharmaceuticals News
Facebook
Rectify Pharmaceuticals on Facebook
YouTube
Rectify Pharmaceuticals on YouTube

Management Team

Title
Name
Email & Social
Chief Executive Officer
Rajesh Devraj
  Rajesh Devraj LinkedIn Profile  Rajesh Devraj Twitter Account  Rajesh Devraj News  Rajesh Devraj on Facebook
Chief Operating Officer
Tracey Dawson
  Tracey Dawson LinkedIn Profile  Tracey Dawson Twitter Account  Tracey Dawson News  Tracey Dawson on Facebook
Chief Scientific Officer
Jonathan Moore
  Jonathan Moore LinkedIn Profile  Jonathan Moore Twitter Account  Jonathan Moore News  Jonathan Moore on Facebook
Vice President
Alastair Garfield
  Alastair Garfield LinkedIn Profile  Alastair Garfield Twitter Account  Alastair Garfield News  Alastair Garfield on Facebook
Vice President
Janeta Popovici-Muller
  Janeta Popovici-Muller LinkedIn Profile  Janeta Popovici-Muller Twitter Account  Janeta Popovici-Muller News  Janeta Popovici-Muller on Facebook

 

 

Browse more venture capital transactions:

Prev: 10/18/2021: NCS Analytics venture capital transaction
Next: 10/18/2021: StudySmarter venture capital transaction

 

Share this article

 

About Our Venture Capital Transactions Database

We record funding rounds that are announced publicly. VC investment data records reported here are derived from news reports and company announcements. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.

 

Additional Resources for Entrepreneurs

Lists of Venture Capital and Private Equity Firms

Franchise Opportunities

Contributors

Business Glossary

 

Copyright © 2001-2024. Gaebler Ventures. All rights reserved.